Nitric oxide and cyclic nucleotides in bovine oocytes matured in vitro

Author(s)

Kátia Regina Lancellotti Schwarz

• Document type: Doctoral Thesis
• Press: Pirassununga.
• Institution: Universidade de São Paulo (USP). Faculdade de Zootecnica e Engenharia de Alimentos (FZE/BT)
• Defense date: 2011-09-30

Examining board members

Cláudia Lima Verde Leal; Paulo Roberto Adona; Flávio Vieira Meirelles; Gisele Zoccal Mingoti; Luciano Andrade Silva

• Advisor: Cláudia Lima Verde Leal

Abstract

The NOS/NO system seems to play an important role in oocyte maturation besides other functions. However, despite the evidence, there are few studies on the possible role of this system in bovine oocytes. It is known that NO acts via guanylate cyclase (GC) by stimulating the production of the nucleotide cGMP, which in turn can influence the levels of another nucleotide, cAMP, which is an important element of the signaling pathway of gonadotropins in oocytes and in the control of oocyte maturation. The aim of the present study was to investigate the involvement of the cGMP pathway in the action of the NOS/NO system on the in vitro maturation (IVM) of bovine oocytes and its effect on the cAMP pathway. The highest studied concentration of the NO donor (10-7M SNAP), only 36% of oocytes were able to undergo GVBD (P<0.05) after 9 hours of maturation. This delay was also observed with different concentrations of the GC stimulator (5, 10 or 50&mu;M Proptoporfirin IX) and the cGMP analogue (1, 2 and 4 mM 8-Br-cGMP), which had an average of 50% GVBD for treatment groups and 70% for control groups without drugs (P<0.05). At the beginning of maturation (0 h) cGMP levels were 5.29 pmol/oocyte and decreased within the first hour of culture to 2.97 pmol and 1.54 pmol in the control group and in oocytes cultured in 10-7M SNAP (NO donor) associated with 100&mu;M OQD (GC inhibitor; P<0.05). In the group of oocytes cultured only with SNAP, cGMP levels remained at 4.51 pmol/oocyte similar to the immature group (0 h culture, P> 0.05). The increase of NO maintained cGMP levels stable only during the first hours of maturation. After 3 and 6 h IVM, cGMP levels remained low and similar (0.01 to 2.5 pmol/ ocyte, P>0.05) in control (without drugs), treated with NO donor (SNAP 10-7M) with or without the guanylate cyclase inhibitor (100&mu;M OQD). A decrease in cAMP levels was also observed when compared with the immature group (32.42 fmol cAMP/oocyte) for the other groups (P <0.05), which showed 12.0 to 16.0 fmol cAMP/oocyte after the first hour, 3.3 to 8.0 fmol/oocyte after the third hour and 7.4 to 18.3 after the sixth hour of IVM (P>0.05). NO and cGMP may act to control gene expression in a series of proteins involved in control of the levels of cAMP and cGMP or their functions. The control may be a direct effect of NO (PKG2, PDE3, PDE4D and PDE8A), cGMP (ADCY6) or NO via cGMP (PKA1) and varies with the compartment considered (oocyte or cumulus cells). The results showed the interrelationship of the NO/cGMP/cAMP pathway and all its complexity depending on the cell type and the stage of maturation in bovine oocytes. (AU)